Impact of untreated CAD on TAVR outcomes
Cardiology Update
JANUARY 28, 2024
The optimal management of concomitant chronic obstructive coronary artery disease (CAD) in transcatheter aortic valve replacement (TAVR) recipients remains a debated topic. While some advocate for pre-TAVR percutaneous coronary intervention, others adopt an expectant approach. European Heart Journal 2024.
Let's personalize your content